Coherus Oncology, Inc. (CHRS) Stock buybacks
Coherus Oncology, Inc. (CHRS) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$2,000FY2016
| Fiscal year | Value | YoY |
|---|---|---|
| FY2016 | $2,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CHRS financial trends
CHRS RevenueCHRS Net incomeCHRS Net marginCHRS Gross profitCHRS Gross marginCHRS Operating incomeCHRS Operating marginCHRS Operating cash flowCHRS Free cash flowCHRS Capital expendituresCHRS Return on equityCHRS Dividends paidCHRS Total assetsCHRS Total liabilitiesCHRS Shareholders’ equityCHRS overview →